SciBase Holding AB (OSTO:SCIB) Cyclically Adjusted Revenue per Share: kr28.77 (As of Mar. 2026)


OSTO:SCIB SciBase Holding AB OSTO:SCIB
55 GF Score
Price kr33.25
GF Value kr21.73
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is SciBase Holding AB Cyclically Adjusted Revenue per Share?

SciBase Holding AB OSTO:SCIB +0.15% 55 Cyclically Adjusted Revenue per Share is kr28.77 as of Mar. 2026. GuruFocus rates OSTO:SCIB with a GF Score™ of 55/100 and a GF Value™ of kr21.73 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

SciBase Holding AB's adjusted revenue per share for the three months ended in Mar. 2026 was kr1.742. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr28.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, SciBase Holding AB's average Cyclically Adjusted Revenue Growth Rate was -8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-08), SciBase Holding AB's current stock price is kr33.25. SciBase Holding AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was kr28.77. SciBase Holding AB's Cyclically Adjusted PS Ratio of today is 1.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of SciBase Holding AB was 1.80. The lowest was 0.66. And the median was 1.02.


SciBase Holding AB  (OSTO:SCIB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SciBase Holding AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=33.25/28.77
=1.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of SciBase Holding AB was 1.80. The lowest was 0.66. And the median was 1.02.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


SciBase Holding AB Cyclically Adjusted Revenue per Share Related Terms


SciBase Holding AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for SciBase Holding AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SciBase Holding AB Cyclically Adjusted Revenue per Share Chart

SciBase Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 32.41 29.40

SciBase Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.28 30.71 30.10 29.40 28.77

OSTO:SCIB vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, SciBase Holding AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Cyclically Adjusted PS Ratio falls into.


OSTO:SCIB
55GF Score
SciBase Holding AB OSTO:SCIB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SciBase Holding AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SciBase Holding AB's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.742/133.5600*133.5600
=1.742

Current CPI (Mar. 2026) = 133.5600.

SciBase Holding AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 10.976 101.019 14.512
201609 9.349 101.138 12.346
201612 10.078 102.022 13.193
201703 10.509 102.022 13.758
201706 12.251 102.752 15.924
201709 7.018 103.279 9.076
201712 8.772 103.793 11.288
201803 5.805 103.962 7.458
201806 4.704 104.875 5.991
201809 4.069 105.679 5.143
201812 5.546 105.912 6.994
201903 7.090 105.886 8.943
201906 10.576 106.742 13.233
201909 9.463 107.214 11.788
201912 12.444 107.766 15.423
202003 12.176 106.563 15.261
202006 5.844 107.498 7.261
202009 5.060 107.635 6.279
202012 4.513 108.296 5.566
202103 3.784 108.360 4.664
202106 3.080 108.928 3.776
202109 3.521 110.338 4.262
202112 4.634 112.486 5.502
202203 5.030 114.825 5.851
202206 4.533 118.384 5.114
202209 6.011 122.296 6.565
202212 5.395 126.365 5.702
202303 5.925 127.042 6.229
202306 5.852 129.407 6.040
202309 5.040 130.224 5.169
202312 4.008 131.912 4.058
202403 4.212 132.205 4.255
202406 2.970 132.716 2.989
202409 3.192 132.304 3.222
202412 3.264 132.987 3.278
202503 2.965 132.825 2.981
202506 2.165 133.699 2.163
202509 2.208 133.480 2.209
202512 2.510 133.390 2.513
202603 1.742 133.560 1.742

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of kr28.77 mean?
SciBase Holding AB (OSTO:SCIB) has a Cyclically Adjusted Revenue per Share of kr28.77 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on SciBase Holding AB and its competitors.
Is SciBase Holding AB's Cyclically Adjusted Revenue per Share too high?
SciBase Holding AB's current Cyclically Adjusted Revenue per Share is kr28.77. Overall, SciBase Holding AB has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SciBase Holding AB's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
SciBase Holding AB's Cyclically Adjusted Revenue per Share of kr28.77 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on SciBase Holding AB and its competitors. SciBase Holding AB's current Cyclically Adjusted Revenue per Share is kr28.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SciBase Holding AB stock overvalued right now?
Based on GuruFocus' analysis, SciBase Holding AB (OSTO:SCIB) is currently considered Significantly Overvalued. The stock's GF Value™ is kr21.73, compared to a current price of kr33.25 — trading 53% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is kr28.77. SciBase Holding AB's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For SciBase Holding AB (OSTO:SCIB), the current Cyclically Adjusted Revenue per Share is kr28.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SciBase Holding AB (OSTO:SCIB) Overvalued in 2026?

Based on GuruFocus' analysis, SciBase Holding AB stock appears to be overvalued. The current stock price of kr33.25 is trading 53% above its estimated GF Value™ of kr21.73. GuruFocus considers SciBase Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:SCIB:

  • Cyclically Adjusted Revenue per Share: kr28.77
  • GF Value™: kr21.73 vs. price of kr33.25 (53% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the OSTO:SCIB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SciBase Holding AB Business Description

Address Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company specializing in early detection of skin cancer and prevention in dermatology. SciBase develops, manufactures, and commercializes Nevisense, a point-of-care technology platform that combines AI (artificial intelligence) and EIS technology to elevate diagnostic accuracy and support the prevention of skin diseases. The company's product portfolio consists of the Nevisense platform technology for multiple clinical applications and proprietary Nevisense electrodes. The products are based on measurements using electrical impedance spectroscopy (EIS), analysed using custom artificial intelligence (AI)-based algorithms. The company operates in two segments, which include skin cancer and skin barrier assessment.
55GF Score

Get the complete analysis for OSTO:SCIB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr33.25
Price
kr21.73
GF Value